Relative Bioavailability of (s) - ( + ) -Ibuprofen Suspension in Human Subjects

ZHANG Yu,MA Li,ZHANG Son-gan,LUO Lei
DOI: https://doi.org/10.3321/j.issn:1001-5213.2006.10.018
2006-01-01
Abstract:OBJECTIVE To study pharmacokinetics and bioavailability of(s)-(+)-ibuprofen suspension and tablets.METHODS A reversed-phase high performance liquid chromatography was employed for the determination of the ibuprofen in plasma after a single oral of 400 mg the suspension and tablets in a crossover design.RESULTS The main pharmacokinetic parameters of the suspension and tablets were:AUC_(0-12)((118.1)±(28.4)) mg·L~(-1)·h and((117.6)±(19.7)) mg·L~(-1)·h,AUC_(0-∞)((119.2)±(29.0)) mg·L~(-1)·h and ((118.6)±(19.7)) mg·L~(-1)·h,C_(max)((32.9)±(6.8)) mg·L~(-1) and((35.7)±(5.1)) mg·L~(-1),t_(max)((1.4)±(0.7)) h and((1.5)±(0.7)) h,respectively.The relative bioavailability of the test suspension was((102.0)±(24.1))%.CONCLUSION The(s)-(+)-ibuprofen suspension and tablet are bioequivalent.
What problem does this paper attempt to address?